Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
Disease-modifying antirheumatic drugs - ScienceDirect
Conventional disease‐modifying antirheumatic drugs to treat rheumatoid arthritis - Rath - 2011 - Drug Development Research - Wiley Online Library
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Disease-modifying antirheumatic drugs | Download Table
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
Biologic DMARDs and targeted synthetic DMARDs approved for the... | Download Scientific Diagram
Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram
Disease-Modifying Antirheumatic Drug - an overview | ScienceDirect Topics
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
The Safety of Antirheumatic Drugs (11.02.2022)
